Peptide directoryBrain, hypothalamus & pituitary

Beta-MSH

A second melanocortin from the lipotropin end of POMC, acting on appetite.

Where it comes from

Made in
POMC neurons of the hypothalamus, and the skin
Sent out by
With the other POMC products
Acts on
  • Hypothalamic MC4R neurons
  • Melanocytes

What it does

  • Suppresses appetite through MC4R, and may be the main natural ligand for that receptor in the human hypothalamus 1
  • A POMC variant, Tyr221Cys, weakens its binding to MC4R and ran with obesity in the families carrying it 1
  • Its pigmentary effects are secondary to alpha-MSH, which binds MC1R far more strongly

In medicine

  • None of its own; the MC4R medicines, setmelanotide among them, act on the receptor it shares with alpha-MSH
  • It is measured only in research, and antibodies raised against it cross-react with the other melanocortins, so a reported level is hard to read 2

Beyond the body’s own use

  • There is no beta-MSH product and no trial of one; what is asked of it is whether it, rather than alpha-MSH, sets appetite in people
  • That question exists because human POMC is cut into beta-MSH and the mouse’s is not, so the mouse work that built melanocortin pharmacology could not test it 1
  • The evidence for a human role is the Tyr221Cys variant and the family studies around it, which is thin ground for a receptor as important as MC4R 1
  • Whether beta-MSH reaches the brain from the blood is unknown, and any attempt at a medicine would have to answer that first

Sources

  1. Lee et al., A POMC variant implicates beta-MSH in the control of human energy balance, Cell Metabolism 2006
  2. Bicknell, The tissue-specific processing of pro-opiomelanocortin, Journal of Neuroendocrinology 2008

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.